Calls to walk through the full list are open today.

Get the full list on a call

Enquirer Consulting Group

Buyer list · Checked

Get the full list on a call
cytovance.comBiologics contract development and manufacturing

Buyer list for Cytovance Biologics · Checked

12 biotech and pharma companies across 5 states that fit what Cytovance Biologics sells, each with the person who signs off.

We read cytovance.com to see what Cytovance Biologics sells, then checked each account below against it, one by one, and named the person who signs off at each. The first 5 are open below with work email and phone. The other 7 come with a short walkthrough call, and you keep the full list.

5 open7 to unlock

Report prepared for

Cytovance Biologics

Biologics contract development and manufacturing

biotech and pharma companies

Tim Rath of Innovative Radiology on working with us

Checked

The opportunity for Cytovance Biologics

The accounts that fit what Cytovance Biologics sells, the market behind them, and who signs off.

12

accounts that fit Cytovance Biologics, each with the person who signs off

SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026

293

biological product makers in the US market

SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total

5

states on the list

SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026

01Buyer list for Cytovance Biologics

Each account checked one by one

First 5 of 12

7

more waiting

Each account fits what Cytovance Biologics sells, and each comes with the person who signs off. The first 5 carry a work email and a phone, checked on .

CompanyWhy it fitsContactStatus

Compass Therapeutics Inc

Thomas Schuetz

Co-Founder, CEO, Vice Chairman of the Board

Boston, MA

Compass Therapeutics Inc is a clinical-stage oncology biopharmaceutical company developing antibody-based therapeutics.

thomas.schuetz@compasstherapeutics.com +1 508 277 3917

Checked

Rezolute, Inc

Nevan Charles Elam

Founder and CEO

Redwood City, CA

Rezolute, Inc is a late-stage biotechnology company developing a monoclonal antibody for hyperinsulinism. Cytovance Biologics runs process development and cGMP manufacturing for antibodies, fusion proteins and enzymes.

nevan@rezolutebio.com +1 650 810 3021

Checked

Trellis Bioscience Inc

Stefan Ryser

President & CEO

Redwood City, CA

Trellis Bioscience Inc is a clinical-stage biotechnology company developing native human monoclonal antibodies.

sryser@trellisbio.com +1 917 880 1638

Checked

LTZ Therapeutics

Robert Li

Founder, CEO

Redwood City, CA

LTZ Therapeutics is a clinical-stage immunotherapy company developing bispecific antibody myeloid cell engagers.

robert.li@ltztherapeutics.com +1 314 956 7892

Checked

Orionis Biosciences

Nikolai Kley

Founder, President and CEO

Waltham, MA

Orionis Biosciences is a clinical-stage biotechnology company designing engineered protein medicines. Cytovance Biologics runs process development and cGMP manufacturing for antibodies, fusion proteins and enzymes.

nkley@orionisbio.com +1 781 223 6115

Checked

Resolve Therapeutics, LLC

Ja***** Po***** CEO and Founder Miami, FL

Unlock CEO and FounderBook a call

Manifold Bio

Gl***** Ku***** Co-Founder and CEO Boston, MA

Unlock Co-Founder and CEOBook a call

Centivax

Ja***** Gl***** Founder, CEO & President South San Francisco, CA

Unlock Founder, CEO & PresidentBook a call

Abilita Therapeutics, Inc

Ma***** Mi***** Founder & CEO San Diego, CA

Unlock Founder & CEOBook a call

Cartography Biosciences

Ke***** Pa***** CEO, Co-Founder South San Francisco, CA

Unlock CEO, Co-FounderBook a call

Innate Biologics, LLC

Pe***** Mo***** CEO, Co-Founder, Equity Partner Newtown Square, PA

Unlock CEO, Co-Founder, Equity PartnerBook a call

Klus Pharma Inc

La***** Ho***** President Princeton, NJ

Unlock PresidentBook a call

7 more accounts are on the list for Cytovance Biologics, each with the person who signs off. They come with a short walkthrough call, and you keep the full list.

Unlock the full list

02The market for Cytovance Biologics

Where these accounts sit, counted from US Census business data.

Total addressable market

293

biological product makers in the US.

By buyer group

biological product makers293

SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total

By company size

Under 20 staff149
20 to 99 staff51
100 to 499 staff32
500 or more staff61

SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total

By state, on the list

California6
Massachusetts3
Florida1
New Jersey1
Pennsylvania1

SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026

Who signs off on the list

CEO11
President1

SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026

What the numbers say

01

About 5 in 10 biological product makers have under 20 staff. That is about 150 of them. 51 have 20 to 99 staff, 32 have 100 to 499 and 61 have 500 or more.

SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total

02

CEOs sign off most often. Of the 12 people who sign off, 11 are CEOs.

SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026

03

Where the larger accounts sit. 32 of the biological product makers have 100 to 499 staff, and 61 have 500 or more.

SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total

03How it runs for you, from the list to the meeting.

In the engagement, intent data and fit pick the accounts. ECG's AI brain reads every reply, scores it and routes it. Your CRM and your team get the meeting, the record and the next step.

  1. Intent and fit

    Once it runs for you, intent data read with fit sets which accounts to reach first.

  2. AI brain

    ECG's own AI reads every reply, scores it and routes it to the right person.

  3. The person who signs off

    Name, title, work email and phone for each account, checked before anyone reaches out.

  4. Workflow automation

    The meeting lands in your calendar, the record lands in your CRM, and the rep gets the alert.

  • Intent data
  • Email replies
  • LinkedIn replies
  • Phone calls
  • Website inquiries
  • Your CRM

ECG AI brain

Reads, scores and routes

  • Meeting booked
  • Account scored
  • Rep alerted
  • Personal reply sent
  • CRM record updated
  • Next step scheduled
Every reply and every intent signal goes through one brain, then out to your calendar, your CRM and your team.

Build, Run, Own

Enquirer Consulting Group

Build. Run. Own.

  1. 01 Build.

    Built for Cytovance Biologics

    The list, the messages, the CRM link and the workflows, set up for your market.

  2. 02 Run.

    Run live with your team for four months

    We run it with your team and prove it on your own numbers.

  3. 03 Own.

    Then you own it

    We hand it over, and the system stays yours.

04What to expect

What we have achieved on our own outbound, and what happens next.

88

interested replies in one week, on our own outbound

SourceInterested replies to our own outbound, one per person, Oct 12 to Oct 18, 2026, read October 18, 2026

31

sales calls booked that same week, on our own outbound

SourceECG booking table, sales calls booked Oct 12 to Oct 18, 2026, one per person, read November 4, 2026

19

industries our own outbound runs in

SourceECG fleet plan, read October 17, 2026

These are our own results. Your numbers depend on your market and your offer.

Recent work includes outreach for BOY Machines, sent in each field rep's own name.

What happens next

  1. 1Ben walks you through all 12 accounts on a short call.
  2. 2You keep the full list.
  3. 3If it fits, we map how the outbound unit runs for Cytovance Biologics.
Get the full list on a call
List readyTalk to BenEnquirer Consulting Group

Get all 12 biotech and pharma companies, with the person who signs off at each.

The first 5 are above. Ben walks you through the other 7 on a short call, and you keep the full list.

Book a call to unlock the full list

Selina from our team may call to walk you through it.

See the full list on a call.

Ben walks you through every account, who signs off at each, and how the outreach runs for Cytovance Biologics.

Get the full list on a call